Calmoseptine Inc. markets Calmoseptine Ointment in all 50 states, Canada, Australia, Philippines, United Arab Emirates, and Jordan. Calmoseptine Inc. has focused its marketing efforts toward hospitals, skilled nursing facilities and home health care agencies. Calmoseptine Inc. is securing pharmacies to stock Calmoseptine Ointment for the convenience of its loyal customers.
Calmoseptine Ointment is Calmoseptine Inc.’s sole product, which has allowed the company to be more innovative, flexible and diverse in marketing. Health care professionals recommend Calmoseptine Ointment because of its unique properties not offered by its competitors.
Calmoseptine Ointment is an effective, multi-purpose moisture barrier that protects and helps heal skin irritations.
Corstrata offers specialized telehealth consultations for the management and prevention of complex wounds, chronic wounds, and ostomies. Corstrata’s consultative program leverages Corstrata’s board-certified Wound/Ostomy Specialists and the latest software platform for wound photography, documentation, live video consults, and care plan collaboration to provide knowledgeable guidance and decision-support to healthcare professionals at the bedside. Corstrata’s value across all care settings and payers includes improving wound healing rates, reducing wound/ostomy related clinician time and cost as well as related supply costs.
PolyMem is a unique versatile dressing designed to control inflammation, reduce pain and increase healing. Each PolyMem dressing includes a hydrophilic polyurethane matrix with a mild, tissue-friendly wound cleanser, a soothing moisturizer, a superabsorbent, and a semi-permeable film backing. This patented formulation of ingredients works synergistically to provide unrivaled benefits for clinicians and patients.
MDM Wound Ventures, Inc, is a veteran owned company that develops and manufactures disruptive and innovative products for advanced wound care and diabetic limb salvage clinicians. EZ Debride, our first product on the market, is a safe, rapid sharp debridement device. Visit our table to appreciate our first-of-its-kind technology.
Medline is the largest privately held manufacturer and distributer of medical supplies uniquely positioned to provide products, education and support across the continuum of care.
MiMedx® is a biopharmaceutical company developing, manufacturing and marketing regenerative biologics utilizing human placental allografts for multiple sectors of healthcare. “Innovations in Regenerative Medicine” is the framework behind our mission to provide physicians with products and tissues to help the body heal itself.
The MolecuLight i:X® introduces real-time diagnostic imaging to wound care. The hand-held MolecuLight i:X device enables visualization of clinically significant (>104 CFU/g) loads of bacteria and provides digital wound area measurement at point-of-care. The i:X uses fluorescence imaging to enhances wound assessment by targeting treatment to the location of bacteria.
Net Health is the leader in software solutions for specialized outpatient care. WoundExpert® powered by xfit® is cloud-based, anywhere access fully-integrated documentation, clinical workflow, scheduling, and billing. Net Health proudly serves 98% of the nation's largest hospital systems and drives workflow for healthcare professionals in 3,000 facilities each day.
SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of shockwave technology used for the repair and regeneration of bones, muscles, tendons and skin, and for the separation of solids and fluid in non-medical systems. Within healthcare, SANUWAVE’s proprietary, patented Pulsed Acoustic Cellular Expression (PACE®) technology emits high-energy, acoustic shockwaves based upon electrohydraulic principles that restore the body’s normal healing processes
At Synergy Biologics, we combine decades of experience in human tissue processing with accomplished track records in advanced tissue biologics product development and regulatory compliance. More specifically, we are a vertically integrated tissue biologics company that specializes in the recovery, processing and distribution of amniotic tissue allografts. This means that we control the quality of each amniotic tissue allograft throughout the entire continuum (tissue recovery, processing and distribution) as well as the costs associated.
Ultimately, our focus is to provide a suite of amniotic tissue based allografts in the most cost effective manner so that more patients have the ability to receive these therapeutic allografts.
Our tissue products include: amniotic membrane grafts, flowable amniotic membrane grafts and umbilical cord derived grafts.